Status:
COMPLETED
Patient Blood Management for Massive Obstetric Hemorrhage
Lead Sponsor:
Angel Augusto Perez Calatayud
Collaborating Sponsors:
Grupo Mexicano para el Estudio de la Medicina Intensiva
Conditions:
Post Partum Hemorrhage
Fibrinogenolysis; Hemorrhage
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Obstetric Hemorrhage continues to be the first cause of maternal morbidity and mortality around the world especially in middle to low income countriesThe blood components are high value resources; how...
Detailed Description
Introduction Obstetric Hemorrhage continues to be the first cause of maternal morbidity and mortality around the world especially in middle to low income countries. Copying trauma transfusion therapie...
Eligibility Criteria
Inclusion
- Patients with severe obstetric hemorrhage of any cause
Exclusion
- obstetric hemorrhage patients derived from other hospitals Patients with less than 1000 ml of estimated blood loss those who do not want to participate in the study
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03784794
Start Date
November 1 2018
End Date
December 30 2020
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Especialidades Del Niño Y La Mujer
Querétaro City, Querétaro, Mexico, 76090